ASTRAZEN - Swing Trade Analysis with AI Signals
Back to ListSwing Trade Rating: 2.8
| Stock Code | ASTRAZEN | Market Cap | 20,896 Cr. | Current Price | 8,370 ₹ | High / Low | 10,691 ₹ |
| Stock P/E | 100 | Book Value | 320 ₹ | Dividend Yield | 0.38 % | ROCE | 33.4 % |
| ROE | 23.6 % | Face Value | 2.00 ₹ | DMA 50 | 8,693 ₹ | DMA 200 | 8,660 ₹ |
| Chg in FII Hold | -0.03 % | Chg in DII Hold | 0.29 % | PAT Qtr | 31.6 Cr. | PAT Prev Qtr | 58.1 Cr. |
| RSI | 36.9 | MACD | -82.7 | Volume | 3,355 | Avg Vol 1Wk | 5,632 |
| Low price | 6,502 ₹ | High price | 10,691 ₹ | PEG Ratio | 2.32 | Debt to equity | 0.04 |
| 52w Index | 44.6 % | Qtr Profit Var | -42.3 % | EPS | 80.4 ₹ | Industry PE | 27.2 |
📊 The stock ASTRAZEN shows weak momentum for swing trading. Current price (₹8,370) is below both 50 DMA (₹8,693) and 200 DMA (₹8,660), indicating bearish sentiment. RSI at 36.9 suggests the stock is near oversold territory, but MACD is negative (-82.7), confirming downward momentum. High P/E (100 vs industry 27.2) makes valuation stretched. Short-term volume is lower than average, showing weak participation.
💡 Optimal Entry Price: Around ₹8,000–8,100 if RSI dips further near 30 and volume improves.
📉 Exit Strategy (if already holding): Consider exiting near ₹8,700–8,800 resistance zone unless strong reversal signals appear.
✅ Positive
- Strong ROCE (33.4%) and ROE (23.6%) indicate efficient capital use.
- Low debt-to-equity (0.04) provides financial stability.
- Dividend yield, though small, adds minor investor return.
⚠️ Limitation
- Extremely high P/E (100) compared to industry average (27.2).
- PEG ratio (2.32) suggests overvaluation relative to growth.
- Weak trading volume compared to average.
📉 Company Negative News
- Quarterly profit dropped sharply (-42.3% variance).
- FII holding decreased (-0.03%), showing reduced foreign investor confidence.
📈 Company Positive News
- DII holding increased (+0.29%), showing domestic institutional support.
- Strong historical high of ₹10,691 indicates potential upside if sentiment improves.
🏭 Industry
- Industry P/E at 27.2 shows peers are valued much lower.
- Sector growth is steady, but ASTRAZEN trades at a premium.
🔎 Conclusion
ASTRAZEN is currently overvalued with weak momentum indicators. It is not an ideal swing trade candidate unless price corrects closer to ₹8,000 with stronger volume. For existing holders, exit near ₹8,700–8,800 is advisable unless a clear reversal trend emerges.